Groundbreaking cell and gene therapy manufacturing and commercialization

We’ve been manufacturing cutting edge cell and gene therapies for over 18 years

cell therapies is an Australian-based, globally-active commercial contract development and manufacturing company, specializing in cell therapy, gene therapy, regenerative medicine, and cellular immunotherapy products.

A leader in this groundbreaking field, our expert team and world-class facilities have been developing and manufacturing cutting edge treatments for cancer and rare diseases on behalf of local and international clients since 2003.

Explore our services

Cell Therapies has extensive experience in the development and commercialization of cell and gene therapies for the Australian and global markets.

Apheresis Management

Over 18 years’ experience managing apheresis collections under GMP quality oversight

Contract Manufacturing

Licensed GMP manufacturing and process development for clinical trials and commercial supply

Clinical Trial Support

Enabling global clinical trial establishment by assisting from trial design to regulatory submission

Consulting and Advisory

The expertise to advance your program from clinical trial through to commercial supply

Industry-leading GMP facility delivering cell and gene therapies from Australia to the world

cell therapies GMP facility is located in Melbourne, Australia, and has manufacturing licences for clinical and commercial supply from Australia’s regulatory agency, the Therapeutic Goods Administration (TGA). Our facility also complies with global regulatory standards for US (FDA), Europe (EMA), Japan (MHLW) and other jurisdictions.

Contact the Cell Therapies Team today

Call Cell Therapies on +61 3 9492 4777 to talk to our expert team or enter your details below and we will contact you to arrange a call at a time that suits you.

Our Partners and Affiliations

Latest News

Victorian State Government

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

| News | No Comments
Professor James Angus has been appointed the new Lieutenant-Governor of Victoria by Her Excellency the Honourable Linda Dessau AC, Governor of Victoria. Professor Angus has had a long and distinguished…

RM Catalyst consortium reports reveal Australia’s potential

| News | No Comments
The RM Catalyst consortium recently published two reports revealing Australia's potential to become a global leader in the regenerative medicine sector. With a reputation for delivering high-quality, complex, and safe…

Announcement from the Chair of the Cell Therapies Board

| News | No Comments
The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle Burke has been appointed as a Non-Executive Director of Cell Therapies Pty Ltd. "Michelle has extensive Board and…

Protecting your cell therapy trial by building resilience in your supply chain

| News | No Comments
Supply chain complexity has always been a factor in healthcare. Drugs are often time- or temperature-sensitive, which make maintaining product quality a significant challenge. But the emergence of cell and…